Remove 2009 Remove FDA Remove Immunization Remove Insurance Coverage
article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

You may be familiar with naltrexone, which is an FDA-approved medication that has been used since the 1980s for opioid withdrawal. However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. Doses of 1.5-4.5

article thumbnail

Top Performing Drug – Enbrel (June Edition)

PharmaShots

In 2009, Pfizer acquired Wyeth thus seeking the rights to Enbrel. Today's FDA approval shows that innovation doesn't stop with a drug's first market approval, and further reflects Amgen's commitment to continually unlock and expand the therapeutic potential of our medicines in the hopes of filling unmet patient needs.